Alphina Therapeutics

Biotechnology

United States, Connecticut

$25M to $50M

11-50

Kate Therapeutics

Biotechnology

United States, California

$25M to $50M

11-50

Hyku Biosciences

Biotechnology

United States, Massachusetts

$25M to $50M

11-50

Dextera Biosciences

Biotechnology

United States, California

$25M to $50M

11-50

Xenoscience

Biotechnology

United States, Arizona

$25M to $50M

11-50

Sanesco International

Biotechnology

United States, North Carolina

$25M to $50M

11-50

BioVescent

Biotechnology

United States, California

$25M to $50M

11-50

Apertura Gene Therapy

Biotechnology

United States, New York

$25M to $50M

11-50

SK Life Science Labs

Biotechnology

United States, Pennsylvania

$25M to $50M

11-50

Impossible Metals

Biotechnology

United States, California

$25M to $50M

11-50

Innovac Therapeutics

Biotechnology

United States, Massachusetts

$25M to $50M

11-50

BioVeritas

Biotechnology

United States, Texas

$25M to $50M

11-50

Matterhorn Biosciences

Biotechnology

United States, Massachusetts

$25M to $50M

11-50

Anthera Pharmaceuticals

Biotechnology

United States, California

$25M to $50M

11-50

Fibrocell Science

Biotechnology

United States, Pennsylvania

$25M to $50M

11-50

Sanavia Oncology

Biotechnology

United States, New York

$25M to $50M

11-50

Gate Bioscience

Biotechnology

United States, California

$25M to $50M

11-50

nexo therapeutics

Biotechnology

United States, Massachusetts

$25M to $50M

11-50

Eureka Biotechnology Co., Limited

Biotechnology

United States, California

$25M to $50M

11-50

Remepy

Biotechnology

United States, California

$25M to $50M

11-50